{
    "title": "Roivant begins giving experimental COVID-19 drug to first U.S. patients",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8222979/Roivant-begins-giving-experimental-COVID-19-drug-U-S-patients.html",
    "date": "2020-04-15",
    "keywords": [
        "drug",
        "ramaswamy",
        "erman",
        "threlfall",
        "gmcsf",
        "cytokine",
        "company",
        "roivant",
        "gimsilumab",
        "trial",
        "executive",
        "vivek",
        "conference",
        "companys",
        "founder",
        "video",
        "interview",
        "protein",
        "granulocytemacrophage",
        "colony",
        "factor",
        "care",
        "increase",
        "class",
        "overreaction",
        "virus",
        "bodys",
        "immune",
        "system",
        "storm",
        "respiratory",
        "distress",
        "covid19",
        "thing",
        "health",
        "crisis",
        "part",
        "answer",
        "difference",
        "dainippon",
        "stake",
        "reporting",
        "editing",
        "adler"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}